IQQL:XETRA:XETRA-iShares Listed Private Equity UCITS (EUR)

ETF | Others |

Last Closing

USD 32.51

Change

+0.33 (+1.03)%

Market Cap

USD 0.79B

Volume

9.30K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.75 (+1.44%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.25 (+1.48%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.37 (+1.36%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.38 (+1.35%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.38%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.74 (+1.90%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.84 (+1.80%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.74 (+1.44%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.59 (+0.61%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.46 (+0.63%)

USD 80.38B

ETFs Containing IQQL:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.96% 78% C+ 78% C+
Dividend Return 1.90% 62% D 45% F
Total Return 19.86% 85% B 83% B
Trailing 12 Months  
Capital Gain 34.03% 90% A- 88% B+
Dividend Return 4.37% 92% A 77% C+
Total Return 38.40% 92% A 89% A-
Trailing 5 Years  
Capital Gain 64.56% 76% C+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.56% 76% C+ 74% C
Average Annual (5 Year Horizon)  
Capital Gain 14.12% N/A N/A 81% B-
Dividend Return 15.87% N/A N/A 84% B
Total Return 1.76% N/A N/A 65% D
Risk Return Profile  
Volatility (Standard Deviation) 25.83% N/A N/A 22% F
Risk Adjusted Return 61.46% N/A N/A 66% D+
Market Capitalization 0.79B 73% C 65% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike